L’Oreal chairman says Coty lacks business model By Investing.com

L’Oreal Chairman Jean-Paul Agon sharply criticized Coty, saying the company has "no business model" as Coty continues to struggle operationally. Coty withdrew full-year guidance in February, warned on third-quarter profits, and is reviewing options for its makeup brands under interim CEO Markus Strobel. The comments are negative for Coty sentiment but are unlikely to move the broader market.

Analysis

This is less about one executive’s insult and more about the market signaling that Coty is drifting into the classic “too small to matter, too weak to fix” zone. Once management credibility breaks, the equity stops trading on category exposure and starts trading on financing optionality: any loss of confidence raises the discount rate, compresses EBITDA multiples, and makes every strategic review look like a liquidation analysis rather than a turnaround. The immediate second-order effect is that suppliers, trade partners, and retail channel counterparties will likely tighten terms before the market fully reprices the stock.

The key read-through for peers is that branded beauty is still bifurcating: global winners with scale in prestige and pricing power can absorb promotional intensity, while subscale players get trapped in margin-dilutive defend-and-donate behavior. That dynamic is supportive for the stronger platforms because weak competitors often “buy” volume with discounting, but the hidden cost is that private-label and mass-market distributors can pick up share faster than the large beauty houses expect if consumers trade down into cheaper alternatives. In other words, the category may not lose demand, but it can migrate down the profit pool.

The catalyst path matters: over the next 1–3 months, any guidance reset, refinancing chatter, or brand-sale announcement would likely create additional downside because the market will assume asset values are being marked to the lowest-quality makeup franchise. Over 6–12 months, the only durable reversal is evidence of sustained gross margin stabilization and a credible capital allocation framework, not another strategic review. If that does not arrive, equity holders are effectively long execution optionality with negative carry.

The contrarian case is that the market may already be pricing “bad news forever,” which can make even modest operational stabilization produce a sharp rally from depressed levels. But that is a trader’s setup, not an investment thesis: you would need signs that SKU rationalization or asset sales are reducing complexity faster than sales are shrinking. Until then, the path of least resistance remains lower because governance noise is compounding fundamental weakness.

Key Decisions for Investors

• Avoid initiating fresh long exposure to COTY until there is explicit evidence of margin stabilization or asset-sale clarity; the next 1–3 months likely carry asymmetric downside if another reset hits.
• For distressed/event-driven mandates, consider a small tactical short in COTY ahead of any refinancing or review milestone; target a 2:1 payoff where downside is driven by multiple compression rather than just earnings misses.
• Pair trade: long stronger beauty platforms vs short COTY on a 3–6 month horizon to isolate quality dispersion in the sector; the trade benefits if capital rotates toward scale and pricing power while weaker names de-rate further.
• If already long COTY, hedge with short-dated puts into the next earnings or strategy update; implied volatility is likely underpricing the probability of another guidance or liquidity shock.